HSA — authorised 19 January 2021
- Marketing authorisation holder: MERCK SHARP DOHME
- Status: likely_approved
HSA authorised Verquvo on 19 January 2021
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 19 January 2021.
MERCK SHARP DOHME holds the Singaporean marketing authorisation.